How to improve your ART success rates : an evidence-based review of adjuncts to IVF / edited by Gab Kovacs.

Cambridge ; New York : Cambridge University Press, 2011.
xii, 262 p. : ill. ; 24 cm.


Related name
Summary note
"There is considerable debate and substantial individual variation in clinical practise regarding what hormones should be assessed in all patients prior to commencing IVF treatment. While it would appear logical to measure multiple hormones such as gonadotrophins (LH, FSH), steroids (testosterone, 17 hydroxy-progesterone), prolactin and thyroid function (TSH, FT4) in all woman with suspected anovulation (irregular menstrual cycle), the utility of such an extensive hormone analysis in the average ovular patient about to commence IVF for male or tubal factor infertility is less certain. In today's environment of escalating medical costs it is imperative that we only order tests that have potential clinical value. Furthermore, abnormal test results can produce anxiety in the patient, an undesirable outcome at a time when the patient is already under considerable psychological distress"--Provided by publisher.
Bibliographic references
Includes bibliographical references and index.
Machine generated contents note: Preface; Part I. Patient Selection and Preparation: 1. Which hormones to measure Kelton P. Tremellen; 2. Imaging -- ultrasound or other? Didier Dewailly; 3. Lapaoscopis and hysteroscopic investigation Bernard Hedon; 4. Polyps and fibroids Ben Kroon; 5. Immunological and coagulation screening W. Kutteh; 6. Blood NK cell activity Gavin Sacks; 7. Weight control Anne Clark; 8. Vitamins and natural therapies Rob Norman and Lisa J. Moran; 9. Role of metformin in polycystic ovary syndrome Adam Balen and Chris Brewer; 10. Endometriosis -- what to treat David Adamson and Mary Abusief; 11. Management of hydrosalpinges Neil Johnson; Part II. The Role of AIH Before IVF: 12. Intrauterine insemination Willem Ombelet; Part III. Stimulation: 13. What stimulation protocol is best? Tony Rutherford; 14. FSH or HMG? Hesham Al-Inany; 15. Agonists vs. antagonists Paul Devroey; 16. Use of the contraceptive pill Gab Kovacs; 17. Role of DHEA Norbet Gleicher; 18. LH add-back Colin Howles; 19. Use of growth hormone Luk Rombauts; 20. Preventing OHSS -- Parlodel, albumin Mohamed Aboulghar; 21. Is IVF the best approach? S. L. Tan; Part IV. Monitoring: 22. How to monitor to get the best results Z. Rosenwaks; Part V. Laboratory: 23. Sperm selection John Aitken; 24. ICSI for all? David Mortimer; 25. Timing of transfer -- day 2/3/4/5/6 David Gardner and Danny Sakkas; 26. Use of cofactors K. Weimer; 27. Metabolomics Danny Sakkas and David Gardner; 28. Role of PGD Anver Kuliev; 29. Assisted hatching Sangeeta Das; Part VI. Embryo Transfer: 30. Role of ultrasound Brad Van Voorhis; 31. Does dummy embryo transfer help? Ragaa Mansour; 32. Does position matter? Sandra Carson; 33. Soft or hard catheters? William Buckett; 34. Bed rest after embryo transfer Gedis Grudzinskas; 35. Sexual intercourse after embryo transfer Kelton P. Tremellen; Part VII. Ancillary Treatments: 36. Place of heparin/aspirin W. Kutteh; 37. E2 supplements Juan Garcia-Velasco; 38. Progesterone supplements Luciano Nardo and Lamiya Mohiyiddeen; 39. Place of prednisolone Pedro Barri; 40. IGI and Humira Mohamed Taranissi; 41. Chinese herbs Sheryl de Lacey; 42. Viagra and hyperbaric oxygen Mark Bowman; 43. Acupuncture Tarek El-Toukhy; 44. Psychotherapy Nick Macklon and Cora de Klerk; 45. Fertility preservation: eggs or ovarian? Kate Stern; Part VIII. Assessment of Results: 46. Reporting of results Liz Sullivan; 47. Why do we need RCTs and how to design them? Johannes L. H. Evers; 48. How to assess Cochrane reports C. Farquhar; Index.
  • 9781107648326 (pbk.)
  • 1107648327 (pbk.)
C - S

Supplementary Information